208 related articles for article (PubMed ID: 28650566)
1. Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1 year continuation rates: a randomised controlled trial.
Korjamo R; Mentula M; Heikinheimo O
BJOG; 2017 Dec; 124(13):1957-1964. PubMed ID: 28650566
[TBL] [Abstract][Full Text] [Related]
2. Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial.
Korjamo R; Mentula M; Heikinheimo O
BJOG; 2017 Dec; 124(13):1965-1972. PubMed ID: 28692170
[TBL] [Abstract][Full Text] [Related]
3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
4. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial.
Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K
Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731
[TBL] [Abstract][Full Text] [Related]
5. The effect of early vs. delayed postpartum insertion of the LNG-IUS on breastfeeding continuation: a systematic review and meta-analysis of randomised controlled trials.
Abdelhakim AM; Sunoqrot M; Amin AH; Nabil H; Raslan AN; Samy A
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):327-336. PubMed ID: 31517549
[No Abstract] [Full Text] [Related]
6. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
Bilgehan F; Dilbaz B; Karadag B; Deveci CD
J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
[TBL] [Abstract][Full Text] [Related]
7. Timing of insertion of levonorgestrel-releasing intrauterine system: a randomised controlled trial.
van der Heijden P; Geomini P; Herman MC; Veersema S; Bongers MY
BJOG; 2017 Jan; 124(2):299-305. PubMed ID: 28012273
[TBL] [Abstract][Full Text] [Related]
8. Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg.
Teunissen AM; Merry AHH; Devies IEC; Roumen FJME
Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):449-456. PubMed ID: 31696740
[No Abstract] [Full Text] [Related]
9. A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement.
Braniff K; Gomez E; Muller R
Aust N Z J Obstet Gynaecol; 2015 Jun; 55(3):279-83. PubMed ID: 26053465
[TBL] [Abstract][Full Text] [Related]
10. Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial.
Korjamo R; Mentula M; Heikinheimo O
Contraception; 2017 Nov; 96(5):344-351. PubMed ID: 28774663
[TBL] [Abstract][Full Text] [Related]
11. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial.
Hohmann HL; Reeves MF; Chen BA; Perriera LK; Hayes JL; Creinin MD
Contraception; 2012 Mar; 85(3):240-5. PubMed ID: 22067762
[TBL] [Abstract][Full Text] [Related]
12. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
13. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond.
Rose SB; Garrett SM; Stanley J
Contraception; 2015 Jul; 92(1):17-25. PubMed ID: 25818594
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
Dominick S; Hickey M; Chin J; Su HI
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
Krashin J; Tang JH; Mody S; Lopez LM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
[TBL] [Abstract][Full Text] [Related]
16. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
[TBL] [Abstract][Full Text] [Related]
17. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.
Bahamondes L; Fernandes A; Bahamondes MV; Juliato CT; Ali M; Monteiro I
Contraception; 2018 Mar; 97(3):205-209. PubMed ID: 29055780
[TBL] [Abstract][Full Text] [Related]
19. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
20. Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
Wildemeersch D; Goldstuck ND; Jackers G
Gynecol Endocrinol; 2017 Mar; 33(3):223-226. PubMed ID: 28084114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
